EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling

Katarzyna Marta Zoltowska iD, Utpal Das, Sam Lismont, Thomas Enzlein, Masato Maesako iD, Mei C Q Houser, Maria Luisa Franco, Burcu Özcan iD, Diana Gomes Moreira iD, Dmitry Karachentsev, Ann Becker, Carsten Hopf und 4 weitere

eLife · 2024

DOI: 10.7554/elife.90690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Katarzyna Marta Zoltowska und 15 weiteren Autor:innen. Beteiligte Einrichtung: VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium. Hauptthemen laut MEDLINE: Amyloid Precursor Protein Secretases, Amyloid beta-Peptides, Alzheimer Disease, Signal Transduction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation Flanders, NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyloid β (Aβ) peptides accumulating in the brain are proposed to trigger Alzheimer’s disease (AD). However, molecular cascades underlying their toxicity are poorly defined. Here, we explored a novel hypothesis for Aβ42 toxicity that arises from its proven affinity for γ-secretases. We hypothesized that the reported increases in Aβ42, particularly in the endolysosomal compartment, promote the establishment of a product feedback inhibitory mechanism on γ-secretases, and thereby impair downstream signaling events. We conducted kinetic analyses of γ-secretase activity in cell-free systems in the presence of Aβ, as well as cell-based and ex vivo assays in neuronal cell lines, neurons, and brain synaptosomes to assess the impact of Aβ on γ-secretases. We show that human Aβ42 peptides, but neither murine Aβ42 nor human Aβ17–42 (p3), inhibit γ-secretases and trigger accumulation of unprocessed substrates in neurons, including C-terminal fragments (CTFs) of APP, p75, and pan-cadherin. Moreover, Aβ42 treatment dysregulated cellular homeostasis, as shown by the induction of p75-dependent neuronal death in two distinct cellular systems. Our findings raise the possibility that pathological elevations in Aβ42 contribute to cellular toxicity via the γ-secretase inhibition, and provide a novel conceptual framework to address Aβ toxicity in the context of γ-secretase-dependent homeostatic signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Precursor Protein SecretasesAmyloid beta-PeptidesAlzheimer DiseaseSignal TransductionNeuronsHumansAnimalsMiceFeedback, PhysiologicalPeptide FragmentsCell Line

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid betaamyloid toxicitybiochemistrychemical biologygamma-secretasegamma-secretase inhibitionhumanmouseneurosciencepresenilinrat

Substanzen

Amyloid Precursor Protein SecretasesAmyloid beta-PeptidesPeptide Fragmentsamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium.
  • Department of Neurosciences, University of California San Diego, La Jolla, United States.
  • Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany.
  • Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, United States.
  • Molecular Basis of Neurodegeneration Unit, Instituto de Biomedicina de Valencia, Valencia, Spain.
  • Medical Faculty, Heidelberg University, Heidelberg, Germany.

ORCID-Profile: Katarzyna Marta Zoltowska, Masato Maesako, Burcu Özcan, Diana Gomes Moreira, Marçal Vilar, Oksana Berezovska, Lucía Chávez-Gutiérrez

Förderung

  • Research Foundation Flanders
  • NIA NIH HHS
  • NIH HHS
  • Spanish Ministry of Science and Innovation
  • Cure Alzheimer's Fund
  • DH Chen Foundation
  • National Institutes of Health
  • Bundesministerium für Bildung und Forschung

Zitieren

APA

Zoltowska, K. M., Das, U., Lismont, S., Enzlein, T., Maesako, M., Houser, M. C. Q., Franco, M. L., Özcan, B., Gomes Moreira, D., Karachentsev, D., Becker, A., Hopf, C., Vilar, M., Berezovska, O., Mobley, W., & Chávez-Gutiérrez, L. (2024). Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling. eLife. https://doi.org/10.7554/elife.90690

Vancouver

Zoltowska KM, Das U, Lismont S, Enzlein T, Maesako M, Houser MCQ, et al. Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling. eLife. 2024. doi:10.7554/elife.90690

BibTeX
@article{Zoltowska2024,
  author = {Zoltowska, Katarzyna Marta and Das, Utpal and Lismont, Sam and Enzlein, Thomas and Maesako, Masato and Houser, Mei C Q and Franco, Maria Luisa and Özcan, Burcu and Gomes Moreira, Diana and Karachentsev, Dmitry and Becker, Ann and Hopf, Carsten and Vilar, Marçal and Berezovska, Oksana and Mobley, William and Chávez-Gutiérrez, Lucía},
  title = {Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.90690}
}
Kostenlos starten →